Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Chimeric antibody to mesothelin

EU orphan designation number: EU/3/08/536   
Active ingredient: Chimeric antibody to mesothelin
Indication: Treatment of pancreatic cancer
Sponsor: Eisai Europe Limited
European Knowledge Centre, Mosquito Way, Hatfield, Herts AL10 9SN, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/03/2008 Centralised Orphan - Designation EMEA/OD/111/07 (2008)1142 of 17/03/2008
08/06/2010 Centralised Orphan - Transfer of orphan designation EMEA/OD/111/07/T/01 (2010)3717 of 04/06/2010